Search
for
Sort by
Research 871–900 of 1000+
- Updates in Treatment for Androgenetic Alopecia
- Design of Nanocrystalline Suspension of Dutasteride for Intramuscular Prolonged Delivery
- Bioprospecting of Potential Inhibitors of 5alpha Reductase 2 Inhibitors from Relevant Ethno-pharmacological Plants via In Silico Techniques
- Gynostemma pentaphyllum Hydrodistillate and Its Major Component Damulin B Promote Hair Growth-Inducing Properties In Vivo and In Vitro via the Wnt/β-Catenin Pathway in Dermal Papilla Cells
- Comment on Current Investigations into the Postfinasteride Syndrome
- Re-Densification Effect of Pressure-Injected Peptide-Hyaluronic Acid Combination on Male Androgenic Alopecia
- Serenoa Repens for the Treatment of Capillary Disorders
- Caizhixuan hair tonic regulates both apoptosis and the PI3K/Akt pathway to treat androgenetic alopecia
- Water extract of cacumen platycladi promotes hair growth through the Akt/GSK3β/β-catenin signaling pathway
- Cosmeceutical Potentials of Equisetum debile Roxb. ex Vaucher Extracts
- Geographical Differences in Male Infertility between the United States and Canada: Insights from the Andrology Research Consortium
- Latanoprost-Loaded Nanotransfersomes Designed for Scalp Administration Enhance Keratinocytes Proliferation
- Gut Inflammation Induced by Finasteride Withdrawal: Therapeutic Effect of Allopregnanolone in Adult Male Rats
- Therapeutic effects of growth factor cocktail (CellcurinTM) containing FGF5s (fibroblast growth factor 5 short) and NMN (nicotinamide mononucleotide) in patients with androgenetic alopecia: A split study
- The Efficacy and Safety of Dr. SKS Hair Booster Serum (a Cocktail of Micronutrients and Multivitamins) in Adult Males and Females With Androgenetic Alopecia: An Open-Label, Non-randomized, Prospective Study
- Compliance to Topical Minoxidil and Reasons for Discontinuation among Patients with Androgenetic Alopecia
- The role of mutations on gene AR, in androgenetic alopecia syndrome
- Androgenic alopecia and dutasteride in hair mesotherapy: A short review
- Tratamento de alopecia androgenética masculina com drug delivery por microagulhamento
- Addressing Androgenetic Alopecia-A Complex Disorder-with a Multilateral Treatment Strategy
- Organic Causes of Erectile Dysfunction in Men Under 40
- 5-Alpha Reductase Inhibitors and Erectile Dysfunction: The Connection
- Persistent erectile dysfunction in men exposed to the 5α-reductase inhibitors, finasteride, or dutasteride
- Shock Wave Therapy for Erectile Dysfunction: Marketing and Practice Trends in Major Metropolitan Areas in the United States
- Erectile Dysfunction in Young Adults: A Narrative Review
- Drug-induced erectile dysfunction: a real-world pharmacovigilance study using the FDA adverse event reporting system database
- IP28-24 RISK OF ERECTILE DYSFUNCTION AMONG REPRODUCTIVE-AGED MEN FOLLOWING LOW-DOSE FINASTERIDE USE FOR ANDROGENETIC ALOPECIA: A PROPENSITY-MATCHED COHORT STUDY
- Population-level risk of erectile dysfunction after finasteride use for androgenetic alopecia: a national cohort analysis
- 332 Recognizing and Treating Undiagnosed Erectile Dysfunction (ED) in Patients Presenting With Lower Urinary Tract Symptoms (LUTS)
- 5α-Reductase inhibitor therapy: Should physicians be concerned with persistent diminished libido, erectile dysfunction and depression in a subset of patients?